Quantum XChange Advances EUCC Milestone and Enterprise Scalability with Latest Release of Phio TX
24.2.2026 13:00:00 CET | Business Wire | Press release
New EUCC Compliance Mode and Enhanced Hive Architecture Strengthen Security for Regulated European and Global Networks
Quantum XChange today announced the latest release of its cryptographic management platform Phio TX® which introduces a new European Union Cybersecurity Certification (EUCC) compliance mode and significant enhancements to its Hive architecture to support massive-scale, distributed deployments.
The release marks a critical milestone toward full EUCC validation for Phio TX and reinforces the company’s commitment to meeting rigorous international security standards for customers operating in regulated European markets.
EUCC is a European Union–wide certification framework based on Common Criteria (ISO/IEC 15408), providing independent evaluation of Information and Communications Technology (ICT) products against high EU cybersecurity standards. Similar in importance to FIPS validation in the United States, EUCC validation is increasingly critical for organizations handling sensitive or regulated data. Phio TX’s new EUCC compliance mode introduces additional product hardening controls, including restrictions on SSH/TLS connections to EUCC-defined cipher suites, strengthening cryptographic assurance and regulatory alignment.
“Cybersecurity certification is a prerequisite for doing business in Europe,” said Eddy Zervigon, CEO of Quantum XChange. “With EUCC compliance mode in Phio TX we’re giving customers a practical path to meet emerging EU requirements while strengthening their defenses against AI- and quantum-driven threats.”
In parallel, Quantum XChange expanded the scalability of its Hive intelligent middleware. Originally introduced in Phio TX version 4.5, the Hive delivers unified key management across distributed nodes, enabling fault tolerance and load balancing while integrating multiple quantum-safe key distribution methods including Post-Quantum Cryptography (PQC) and Quantum Key Distribution (QKD) within a single framework.
The Phio TX 4.5.3 release adds new hub, spoke, and entropy roles designed to support deployments spanning tens of thousands of nodes, including spokes operating behind dynamic IP addresses—common in large enterprise, telecom, and government networks. These enhancements improve operational resilience and simplify cryptographic management at scale.
“Across Europe, quantum-safe migration is accelerating—driven not only by EUCC, but by broader NIS2 obligations, growing data sovereignty requirements, and increasing awareness of Harvest Now, Decrypt Later risks,” said Fabien Adouani, Vice President of Business Development, Europe, at Quantum XChange. “With this Phio TX release, we’re helping organizations align with evolving EU standards while deploying a scalable, crypto-agile architecture that protects critical data today and prepares networks for the post-quantum future.”
Phio TX is Quantum XChange’s cryptographic management platform designed to secure the network layer—the largest attack surface—by separating key generation and delivery from data transmission. This architectural approach strengthens existing encryption infrastructure and enables seamless migration to post-quantum cryptography without costly rip-and-replace upgrades. To request a product demonstration go to: https://info.quantumxc.com/lp-request-demo.
About Quantum XChange
Quantum XChange® empowers leading government agencies and commercial enterprises to secure sensitive network data from advances in AI and quantum computing by protecting their data in motion today and for the post-quantum world. The company’s cryptographic management platform, Phio TX®, provides an open, secure, and flexible architecture solution.
For more information, visit www.quantumxc.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260224335506/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Intersolar Europe: European Solar Industry Responds to Market Changes: Focus on Hybrid PV and New Financing Models24.2.2026 14:30:00 CET | Press release
The European solar market continues to grow. According to SolarPower Europe’s latest European Market Outlook, 2025 marked another strong year for photovoltaics (PV) within the European Union. When it comes to annual expansion rates, Germany is at the top of the list, followed by Spain, France, Italy and Poland. The importance of solar energy in meeting Europe’s power needs continues to grow. At the same time, many countries are changing their subsidies and financing models, creating new challenges for investors. While regulatory instruments, such as contracts for difference (CFDs), provide a new order, the industry is responding with market-based solutions, such as hybrid PV power plants and hybrid power purchase agreements (PPAs). Intersolar Europe offers guidance: At The smarter E Europe, Europe’s largest alliance of exhibitions for the energy industry at Messe München, trade visitors can experience innovations, discuss new business models and meet project developers, manufacturers a
LMR Unveils Tonka Bean CO₂ Absolute: Gourmand Excellence from Planet-Friendly Extraction24.2.2026 14:15:00 CET | Press release
True-to-nature gourmand richness achieved with renewable CO2 technology. IFF (NYSE: IFF) — LMR Naturals by IFF—a global leader in natural ingredients for perfumery, cosmetics and flavors—has introduced Tonka Bean CO₂ Absolute to its Conscious Collection, a line of 12 highly sustainable and traceable natural ingredients for perfumes and flavors. Tonka Bean CO₂ Absolute is a natural extract with a gourmand olfactive signature. This new addition to the perfumer’s palette is produced with renewable and recycled supercritical CO2 at IFF’s extraction site in Aubrac, France. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260224233830/en/ Tonka Bean CO₂ Absolute extracted by LMR. “Our CO₂ extraction unit in Aubrac has enabled LMR to develop a collection of extracts that seamlessly blends sustainability with high hedonic profiles for perfumers," said Bertrand de Préville, general manager of LMR Naturals by IFF. "With the launch of To
NorthX Biologics and Demeetra Announce Strategic Collaboration to Deliver a Faster, Lower-Risk Path from Gene to GMP24.2.2026 14:00:00 CET | Press release
NorthX Biologics and Demeetra today announced a strategic collaboration combining a best-in-class high-titer GS (-/-) CHO cell line with full freedom to operate and no additional IP-related costs, together with advanced cell line development technologies and high-quality process development, MCB banking, and GMP manufacturing services. The collaboration is designed to help biotech companies reach IND-enabling and clinical milestones faster, with fewer technical setbacks and without the need to rebuild cell lines or re-qualify processes when transitioning to a manufacturing partner. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260224427714/en/ Supporting stable, high-titer cell line development and seamless GMP advancement. The partnership combines Demeetra’s CleanCut™ CHO platforms and stable CLD services with NorthX Biologics’ proven GMP production capabilities, process scale-up expertise including fill and finish, and re
AdvanCell Showcases Novel TheraPb Phase 2 Study Design of ADVC001 for the Treatment of Metastatic Prostate Cancer at ASCO GU Symposium 202624.2.2026 14:00:00 CET | Press release
-- The trial uses a response-driven dosing strategy and extended treatment across three prostate cancer populations, supported by the favorable clinical, pharmacokinetic and dosimetry results from Phase 1b -- AdvanCell, a clinical-stage radiopharmaceutical company developing innovative targeted alpha therapies for cancer, today announced the novel Phase 2 design of the ongoing TheraPb clinical trial of ADVC001 in metastatic prostate cancer. ADVC001 is an investigational Lead-212-based prostate-specific membrane antigen (PSMA)-targeted alpha therapy. The study design will be showcased in a ‘Trials in Progress’ poster this week at the American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU 2026) in San Francisco, CA. The TheraPb Phase 2 is an open-label, randomized expansion study incorporating dose optimization strategies in three groups of patients with metastatic hormone-sensitive (mHSPC) and castration-resistant prostate cancer (mCRPC). The study’s innovative d
Axelera AI Secures More Than $250 Million Funding on Global Commercial Growth24.2.2026 14:00:00 CET | Press release
European AI semiconductor leader earns backing from funds managed by Innovation Industries and SiteGround Capital along with EU institutions; edge-first architecture addresses AI's critical energy and cooling constraints Axelera AI, the European leader in AI acceleration hardware, announced its latest funding round led by Innovation Industries, with participation from prominent funds and accounts including BlackRock and SiteGround Capital as new investors, as well as existing investors Bitfury, CDP Venture Capital, European Innovation Council Fund, Federal Holding and Investment Company of Belgium (SFPIM), Invest-NL, Samsung Catalyst Fund, and Verve Investments. Axelera AI has attracted over $450 million in equity, grants and venture debt since incorporating in July 2021. The largest investment ever in an EU AI semiconductor company comes as Axelera ships to its 500th global customer across physical AI and edge AI in industries including defense and public safety, industrial manufactur
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom